Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016927
Chunk: 99

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 99
---
 efforts for CyPath ®Lung, partially offset by a reduction in legal and professional fees.

Other Income (Expense)

|                                |     |   Year Ended 
 December 31, |         |   |     |      |         |   |     | Change in 2024 
 Versus 2023    |         |   |     |   |      |    |
|:-------------------------------|:----|-------------:|--------:|:--|:----|-----:|--------:|:--|:----|:---------------|--------:|:--|:----|:--|-----:|:---|
|                                |     |         2024 |         |   |     | 2023 |         |   |     | $              |         |   |     | % |      |    |
| Interest (expense) income, net |     |            $ | (74,865 | ) |     |    $ |  85,006 |   |     | $              | 159,871 |   |     |   | (188 | )% |
| Other income (expense), net    |     |              |     129 |   |     |      | (27,796 | ) |     |                | (27,925 | ) |     |   | (100 | )% |
| Total other (expense) income   |     |            $ | (74,736 | ) |     |    $ |  57,210 |   |     | $              | 131,946 |   |     |   |  231 | %  |

Other net income (expense) totaled $129 and $(27,796) for the years ended December 31, 2024 and 2023, respectively, an increase of approximately $28,000, or 100%. The net other expense for the year ended December 31, 2023 related to the loss on the disposal of an asset and other non-operating costs. The net other income for the year ended December 31, 2024 related to approximately a $9,000 gain on a sale of an asset and offset by property taxes.

Interest income (expense)

We had net interest (expense) income of approximately $(74,865) and $85,006 for the years ended December 31, 2024 and 2023, respectively. The prioryear amount related to approximately $120,000 interest earned from money market account partially offset